Illumina Announces Roadmap to Five Million Variants for Next-Generation Whole-Genome Genotyping
October 21, 2009
HONOLULU -- At the 59th annual meeting of the American Society of Human Genetics, Illumina, Inc. (NASDAQ:ILMN) today announced its 2010 roadmap for the Infinium whole-genome genotyping platform, offering products capable of analyzing up to five million (5M) variants per sample. As part of this announcement, Illumina outlined an ongoing collaboration with leading researchers to [...]
Zygo Announces Leadership Transition Plan
October 21, 2009
MIDDLEFIELD, CT -- Zygo Corporation (NASDAQ:ZIGO - News) today announced that Chief Executive Officer J. Bruce Robinson, 67, will be retiring after leading the Company for over ten years. Mr. Robinson plans to transition from his current role as CEO and director into a non-director consulting position with ZYGO. The transition is expected to occur [...]
Protein Discovery and New Objective Announce Strategic Co-Marketing Collaboration
October 21, 2009
KNOXVILLE, TN and WOBURN, MA -- Protein Discovery, Inc. and New Objective, Inc. today announced that they have entered into a strategic co-marketing and development agreement designed to enable and expand key applications for intact protein analysis using mass spectrometry ("top down" proteomics). The companies intend to co-market their respective product lines focused on "sample [...]
Life Technologies SOLiD™ 3 Plus System
October 21, 2009
Life Technologies Delivers Enhanced Next-Generation Genomic Analysis Technology for Large-Scale Resequencing Projects - SOLiD™ 3 Plus Enables Higher Throughput, Decreased Cost, and Faster Data Analysis on Life Science Industry’s Most Accurate Sequencing Platform CARLSBAD, Calif. -- Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE) today announced the commercial availability of the SOLiD™ 3 Plus System, [...]
GE Launches $250 Million Healthymagination Fund
October 21, 2009
New equity investment fund to invest in high potential healthcare technology companies; Supports GE’s global Healthymagination initiative, focusing on cost, access and quality. Fairfield, CT, USA – GE (NYSE: GE) announced today the formation of the “GE Healthymagination Fund”, a new equity fund that will make investments in highly promising healthcare technology companies. The fund [...]
Carl Zeiss Introduces Barrier-Breaking Superresolution Microscope Systems
October 21, 2009
Resolution Beyond the Diffraction Limit JENA/Germany, CHICAGO/Illinois/USA -- Carl Zeiss is launching new systems for optical sectioning during the annual Society for Neuroscience’s Neuroscience 2009 meeting to be held in Chicago from October 17th to October 21st. The ELYRA product family features several new superresolution microscopy methods and significantly expands the application of light microscopy [...]
CellAura signs major supply deal with leading international drug discovery group
October 21, 2009
Latest success for Nottingham biopharma cluster Nottingham, UK – CellAura, the leading producer of fluorescence reagents for drug discovery and life sciences research, today announced a development partnership with Cisbio Bioassays. Under the terms of the agreement, CellAura will provide pharmacologically validated reagents to Cisbio Bioassays that will be applied to Cisbio Bioassays’ Tag-lite™ range [...]
October 21, 2009
Residency Training Program Incorporates Personal Genomics into Physician Education BOSTON & FOSTER CITY, Calif. -- Beth Israel Deaconess Medical Center and Navigenics, Inc., a leading personal genomics company, today announced a collaboration to make personalized genomics available to doctors in training. Beth Israel Deaconess Medical Center (BIDMC) has launched the Personalized Genomics and Next Generation [...]
Centice Corporation Closes on $6.1 Million Series C Financing
October 21, 2009
Funds to Support Commercialization of Innovative PASS Rx® System - Centice Corporation, a pioneer in drug verification and safety products, announced today the successful completion of a $6.1 million Series C financing from its existing investors along with a new investor, Fulcrum Financial Group, LP. Morrisville, NC (PRWEB) -- Centice Corporation, a pioneer in drug [...]
Exact Sciences Licenses Hologic’s Invader Detection Chemistry
October 20, 2009
MADISON, Wis. -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has obtained a worldwide license from Hologic Inc. for that company’s Invader, Invader plus and real-time Invader detection chemistries for the field of colorectal cancer screening. Financial terms of the license agreement were not disclosed. The Invader chemistry, which is being commercialized by [...]

